Wedbush Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.3M Sell
49,640
-4,549
-8% -$436K 0.13% 124
2025
Q4
$5.21M Buy
54,189
+8,391
+18% +$815K 0.15% 92
2025
Q3
$4.36M Buy
45,798
+10,091
+28% +$928K 0.14% 106
2025
Q2
$3.11M Sell
35,707
-86
-0.2% -$7.29K 0.11% 136
2025
Q1
$3.22M Buy
35,793
+1,311
+4% +$117K 0.12% 129
2024
Q4
$2.75M Buy
34,482
+4,022
+13% +$348K 0.1% 150
2024
Q3
$2.74M Sell
30,460
-3,982
-12% -$335K 0.1% 148
2024
Q2
$2.71M Buy
34,442
+1,165
+4% +$95.5K 0.1% 148
2024
Q1
$2.9M Buy
33,277
+4,150
+14% +$354K 0.11% 145
2023
Q4
$2.4M Sell
29,127
-1,261
-4% -$96.1K 0.11% 141
2023
Q3
$2.38M Buy
30,388
+1,399
+5% +$117K 0.12% 132
2023
Q2
$2.55M Sell
28,989
-1,601
-5% -$138K 0.12% 126
2023
Q1
$2.47M Buy
30,590
+2,901
+10% +$236K 0.12% 133
2022
Q4
$2.15M Buy
27,689
+4,787
+21% +$388K 0.12% 135
2022
Q3
$1.85M Sell
22,902
-2,379
-9% -$214K 0.1% 152
2022
Q2
$2.27M Sell
25,281
-405
-2% -$41K 0.12% 128
2022
Q1
$2.85M Buy
25,686
+672
+3% +$71K 0.13% 124
2021
Q4
$2.59M Sell
25,014
-1,864
-7% -$216K 0.11% 149
2021
Q3
$3.37M Buy
26,878
+1,836
+7% +$238K 0.16% 101
2021
Q2
$3.11M Sell
25,042
-1,296
-5% -$163K 0.15% 114
2021
Q1
$3.11M Buy
26,338
+3,840
+17% +$450K 0.17% 99
2020
Q4
$2.63M Buy
22,498
+923
+4% +$102K 0.23% 91
2020
Q3
$2.24M Sell
21,575
-2,389
-10% -$240K 0.22% 102
2020
Q2
$2.2M Buy
23,964
+3,602
+18% +$345K 0.21% 106
2020
Q1
$1.84M Buy
20,362
+52
+0.3% +$5.53K 0.22% 105
2019
Q4
$2.3M Sell
20,310
-442
-2% -$48.5K 0.2% 110
2019
Q3
$2.25M Buy
20,752
+1,151
+6% +$120K 0.22% 96
2019
Q2
$1.91M Sell
19,601
-577
-3% -$52.7K 0.19% 119
2019
Q1
$1.84M Buy
20,178
+293
+1% +$26.2K 0.2% 116
2018
Q4
$1.81M Buy
19,885
+4,114
+26% +$384K 0.23% 100
2018
Q3
$1.55M Sell
15,771
-70
-0.4% -$6.47K 0.18% 126
2018
Q2
$1.36M Buy
15,841
+5,448
+52% +$455K 0.17% 140
2018
Q1
$834K Sell
10,393
-2,398
-19% -$198K 0.11% 221
2017
Q4
$1.03M Buy
12,791
+1,575
+14% +$126K 0.13% 195
2017
Q3
$872K Sell
11,216
-136
-1% -$11.3K 0.11% 207
2017
Q2
$1.01M Buy
11,352
+46
+0.4% +$3.88K 0.13% 189
2017
Q1
$911K Sell
11,306
-1,254
-10% -$98K 0.12% 200
2016
Q4
$895K Sell
12,560
-1,616
-11% -$127K 0.13% 187
2016
Q3
$1.23M Sell
14,176
-1,299
-8% -$113K 0.18% 117
2016
Q2
$1.34M Buy
15,475
+3,857
+33% +$312K 0.22% 103
2016
Q1
$871K Sell
11,618
-969
-8% -$73K 0.15% 149
2015
Q4
$968K Buy
12,587
+726
+6% +$54.7K 0.17% 124
2015
Q3
$794K Buy
11,861
+470
+4% +$34.6K 0.16% 148
2015
Q2
$844K Buy
11,391
+1,129
+11% +$86.3K 0.16% 155
2015
Q1
$800K Buy
10,262
+3,406
+50% +$258K 0.14% 170
2014
Q4
$495K Sell
6,856
-1,821
-21% -$126K 0.08% 271
2014
Q3
$538K Sell
8,677
-50
-0.6% -$3.18K 0.08% 249
2014
Q2
$556K Sell
8,727
-584
-6% -$35.5K 0.09% 240
2014
Q1
$573K Buy
9,311
+313
+3% +$18.2K 0.1% 216
2013
Q4
$516K Buy
8,998
+466
+5% +$26.4K 0.12% 196
2013
Q3
$454K Sell
8,532
-542
-6% -$29.2K 0.12% 202
2013
Q2
$467K Buy
+9,074
New +$449K 0.13% 192

Other funds holding MDT

Wedbush Securities's MDT Position: Q1 2026 in Review

Wedbush Securities reduced its Medtronic (MDT) stake by 8.4% in Q1 2026, selling an estimated $436K and leaving 49,640 shares worth $4.3M. The position accounts for 0.13% of the portfolio, ranked #124.

Wedbush Securities first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.21M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Wedbush Securities held 49,640 shares of Medtronic worth $4.3M as of Q1 2026.
  • Wedbush Securities sold 4,549 Medtronic shares in Q1 2026, an estimated $436K.
  • Medtronic made up 0.13% of Wedbush Securities's portfolio in Q1 2026, its #124 holding.
  • Wedbush Securities first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Wedbush Securities's Medtronic position peaked at $5.21M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.